AIM ImmunoTech Inc.
AIM · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $11,203 | $21,378 | $14,895 | $43,553 |
| - Cash | $1,701 | $5,439 | $27,053 | $32,093 |
| + Debt | $2,941 | $718 | $837 | $149 |
| Enterprise Value | $12,443 | $16,657 | -$11,321 | $11,609 |
| Revenue | $170 | $202 | $141 | $135 |
| % Growth | -15.8% | 43.3% | 4.4% | – |
| Gross Profit | $139 | $160 | $565 | -$715 |
| % Margin | 81.8% | 79.2% | 400.7% | -529.6% |
| EBITDA | -$16,489 | -$28,724 | -$19,869 | -$18,285 |
| % Margin | -9,699.4% | -14,219.8% | -14,091.5% | -13,544.4% |
| Net Income | -$17,320 | -$28,962 | -$19,445 | -$19,127 |
| % Margin | -10,188.2% | -14,337.6% | -13,790.8% | -14,168.1% |
| EPS Diluted | -0.31 | -0.6 | -0.44 | -0.45 |
| % Growth | 48.3% | -36.4% | 2.2% | – |
| Operating Cash Flow | -$14,888 | -$21,267 | -$16,108 | -$13,965 |
| Capital Expenditures | -$18 | -$585 | -$271 | -$633 |
| Free Cash Flow | -$14,906 | -$21,852 | -$16,379 | -$14,598 |